◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › PHAT

Phathom Pharmaceuticals, Inc. (PHAT) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

Phathom Pharmaceuticals, Inc. (PHAT) operates in the Biotechnology industry and is headquartered in Florham Park, United States with about 371 employees. Its market capitalization is roughly $970 million. In the fiscal year ended 2025-12-31, PHAT reported $175M in revenue and ($221M) in net income.

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States.

Interactive charts & full statements → Open the PHAT valuation workbench →

PHAT Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$175M$55M$1M$0M
Gross Profit$152M$47M$0M$0M
Operating Income (EBIT)($160M)($278M)($167M)($172M)
Net Income($221M)($334M)($202M)($198M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PHAT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$58M$58M$50M$40M$28M
Gross Profit$46M$50M$43M$34M$25M
Operating Income (EBIT)($16M)($6M)($15M)($60M)($79M)
Net Income($30M)($21M)($30M)($76M)($94M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PHAT Free Cash Flow History

PHAT Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$259M$378M$414M$165M
Total Liabilities$697M$632M$487M$240M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PHAT viewer.

Other Companies in Biotechnology

← PHARAll stocksPHG →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.